Clinical Trials Insight: 700012151
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2007
At a glance
- Drugs Iclaprim (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Evolva Holding SA
- 29 Aug 2007 Status changed from in progress to completed.
- 15 Feb 2006 New trial record.